Pharmaceutical Industry
Thomas Struengmann & Family: The Silent Powerhouses Behind Global Healthcare Innovation
Thomas Struengmann and his family have become synonymous with discretion, influence, and monumental impact within the global healthcare and pharmaceutical industries. Despite their...
Andreas Struengmann & Family: The Silent Giants of Global Pharma
Andreas Struengmann, alongside his twin brother Thomas, stands as one of the most influential yet understated figures in the global pharmaceutical industry. Born...
Jiang Rensheng & Family: The Visionaries Behind China’s Vaccine Empire
Jiang Rensheng, a name that once might have been known only in pharmaceutical and business circles in China, has become a symbol of...
Cyrus Poonawalla: The Vaccine King of India
Cyrus Poonawalla is a name synonymous with life-saving vaccines and global health innovation. As the founder and chairman of the Serum Institute of...
Legacy and Leadership: How Tse Ping & Family Continue to Shape the Global Pharmaceutical Industry
As of January 2025, the Tse family continues to be a prominent force in the pharmaceutical industry, with significant developments marking their recent...
Peter Gassner: Pioneering the Future of Cloud Software in Life Sciences
Peter Gassner, born in 1965, is a distinguished American entrepreneur renowned for his significant contributions to the software industry, particularly within the life...
Stéphane Bancel: Leading Moderna’s Evolution and Innovation
Stéphane Bancel, born on July 20, 1972, in Marseille, France, has emerged as a pivotal figure in the biotechnology sector. Currently serving as...
Egor Kulkov: The Reclusive Architect of Russia’s Pharmaceutical Empire
Egor Nikolaevich Kulkov, born on December 7, 1971, in Novosibirsk, Russia, is a prominent yet enigmatic figure in the global pharmaceutical industry. With...
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion, Expanding Mental Health Portfolio
In a significant move that reshapes the landscape of mental health therapeutics, Johnson & Johnson (NYSE: JNJ) announced today its acquisition of Intra-Cellular...
Moderna Stock Plunges as Company Slashes 2025 Revenue Forecast and Announces Major Cost Cuts
Moderna (NASDAQ: MRNA) shares tumbled 18% in premarket trading on Monday after the biotechnology company significantly lowered its 2025 revenue forecast and announced...
